EUVIMEDEUVIMED entdecken
Crossref

Efficient and High‐Resolution Separation of Partial, Empty, and Full AAV Capsids by Optimized Iodixanol Density Gradient Ultracentrifugation

Shan Fang iD, Jun Wu, Yanfang Shen, Dandan Qi, Zhuoyu Ni, Fenghua Wang

Biotechnology Journal · 2026

DOI: 10.1002/biot.70319 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, 2026. Verfasst von Shan Fang und 5 weiteren Autor:innen. Beteiligte Einrichtung: InnoStellar Biotherapeutics Co., Ltd., Shanghai, China. Hauptthemen laut MEDLINE: Dependovirus, Triiodobenzoic Acids, Capsid. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinant adeno‐associated virus (rAAV) vectors are essential for gene therapy, but their production generates empty and partial capsids as product‐related impurities that can compromise efficacy and safety. While empty capsids have been partially characterized, the isolation and study of partial capsids remain hindered by a lack of robust separation methods. Here, we present an optimized iodixanol density gradient ultracentrifugation strategy enabling high‐resolution separation and enrichment of empty, partial, and full AAV capsids. Key innovations include expanding the 40% iodixanol layer to create a broader intermediate‐density zone and implementing controlled bottom‐puncture fractionation. Applied to a rAAV2 preparation, this method enriched partial capsids from 18.9% in the starting material to approximately 94.9% in the target fraction (determined by AUC integration under the equal response assumption). For a rAAV2 variant with a low baseline of partial capsids (1.3%), over 20‐fold enrichment was achieved, reaching 30.1% purity as determined by AUC integration under the equal response assumption. This approach provides partial‐capsid‐enriched fractions, enabling detailed characterization of partial capsids, supporting critical quality attribute assessment, and facilitating the development of safer, more effective rAAV‐based therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusTriiodobenzoic AcidsCapsidCentrifugation, Density GradientHumansGenetic VectorsHEK293 CellsCapsid Proteins

Stichwörter der Autor:innen

AAVdensity gradient ultracentrifugationempty capsidsfull capsidsiodixanolpartial capsids

Substanzen

iodixanolTriiodobenzoic AcidsCapsid Proteins

Autor:innen und Institutionen

  • InnoStellar Biotherapeutics Co., Ltd., Shanghai, China.

ORCID-Profile: Shan Fang

Zitieren

APA

Fang, S., Wu, J., Shen, Y., Qi, D., Ni, Z., & Wang, F. (2026). Efficient and High‐Resolution Separation of Partial, Empty, and Full AAV Capsids by Optimized Iodixanol Density Gradient Ultracentrifugation. Biotechnology Journal. https://doi.org/10.1002/biot.70319

Vancouver

Fang S, Wu J, Shen Y, Qi D, Ni Z, Wang F. Efficient and High‐Resolution Separation of Partial, Empty, and Full AAV Capsids by Optimized Iodixanol Density Gradient Ultracentrifugation. Biotechnology Journal. 2026. doi:10.1002/biot.70319

BibTeX
@article{Fang2026,
  author = {Fang, Shan and Wu, Jun and Shen, Yanfang and Qi, Dandan and Ni, Zhuoyu and Wang, Fenghua},
  title = {Efficient and High‐Resolution Separation of Partial, Empty, and Full AAV Capsids by Optimized Iodixanol Density Gradient Ultracentrifugation},
  journal = {Biotechnology Journal},
  year = {2026},
  doi = {10.1002/biot.70319}
}
Kostenlos starten →